Doxycycline inhibits bone resorption by human interface membrane cells from aseptically loose hip replacements

Journal of Bone and Joint Surgery - Series B

Volumn 85, Issue 3, 2003, Pages 456-461

  Ong, S M ^a   Taylor, G J S ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM 45; DOXYCYCLINE; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; ASEPSIS; BIOLOGICAL MODEL; BONE CELL; CALVARIA; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; ISOTOPE LABELING; MOUSE; NEWBORN; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; SUPERNATANT; TOTAL HIP PROSTHESIS; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BONE RESORPTION; CELL SURVIVAL; CELLS, CULTURED; DOXYCYCLINE; FEMALE; HIP PROSTHESIS; HUMANS; MALE; MATRIX METALLOPROTEINASES; MICE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PROSTHESIS FAILURE;

EID: 0037396421     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.85B3.13151     Document Type: Article

References (35)

1. Malchau H, Herberts P, Söderman P, Odén A. Prognosis of total hip replacement: update and validation of results from the Swedish National Hip Arthroplasty Register 1979-1998. 67th Annual Meeting American Academy of Orthopaedic Surgeons, 2000.
2. Harris WIL Schiller AL, Scholler JM, Freiberg RA, Scott R. Extensive localized bone resorption in the femur following total joint replacement. J Bone Joint Surg [Am] 1976;58-A:612-8.
3. Goldring SR, Schiller AL, Roelke M, et al. The synovial-like membrane at the bone cement interface in loose total hip replacement and its proposed role in bone lysis. J Bone Joint Surg [Am] 1983;65-A:575-84.
4. Haynes DR, Rogers SD, Hay S, Pearch MJ, Howie DW. The differences in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chrome alloy particles. J Bone Joint Surg [Am] 1993;75-A:799-801.
5. Pazzaglia UE, Cecilliani L, Wilkinson MJ, Dell'Orbo C. Involvement of metal particles in loosening of metal-plastic total hip prostheses. Arch Orthop Trauma Surg 1985;104:164-74.
6. Boynton E, Waddell JP, Morton J, Gardiner GW. Aseptic loosening in total hip implants: the role of polyethylene wear debris. Can J Surg 1991;34:599-605.
7. Willert HG, Bertram G, Buchhorn GIL Osteolysis in alloarthroplasty of the hip: the role of ultra high molecular weight polyethylene wear particles. Clin Orthop 1990;258:95-107.
8. Horrowitz SM, Doty SB, Lane JM, Burstein AH. Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg [Am] 1993;75-A:802-13.
9. Yoon TR, Rowe SM, Jung ST, Seon KJ, Maloney WJ. Osteolysis in association with total hip arthroplasty with ceramic bearing surfaces. J Bone Joint Surg [Am] 1998;80-A:1459-68.
10. Horrowitz SM, Purdon MA. Mechanisms of cellular recruitment in aseptic loosening of prosthetic joint implants. Calcif Tissue Int 1995;57:301-5.
11. Pollice PF, Silverton S, Horrowitz SM. Polymethylmethacrylate stimulated macrophages increase osteoclast precursor recruitment through their effect on osteoblasts in vitro. J Orthop Res 1995;13:325-34.
12. Athanasou NA, Quinn J, Bulstrode CJK. Resorption of bone by inflammatory cells derived from the joint capsules of hip arthroplasties. J Bone Joint Surg [Br] 1992;74-B:57-62.
13. Sims N, Baron R. Bone cells and their function. In: Ernesto Canalis, ed. Skeletal growth factors. Lippincott Williams & Wilkins, 2000:1-16.
14. Nagase H, Woessner JF, Jr. Matrix metal loproteinases. J Biol Chem 1999;274:21491-4.
15. Okada Y, Naka K, Kawamura K, et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Investig 1995;72:311-22.
16. Takagi M, Konttinen Y, Santavirta S, et al. Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 1994;65:281-6.
17. Yokohama Y, Matsumoto T, Hirakawa M, et al. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Lab Invest 1995;72:899-911.
18. Yu Y, Walsh WR, Sonnabend DH, et al. Cytokines and matrix metalloproteinases mRNA expression in archival human tissues from failed hip arthroplasty using in situ hybridization and color video image analysis. Bull Hosp J Dis 1998;57:23-9.
19. Greenwald RA, Golub LM, Lavietes B, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987; 14:28-32.
20. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-322.
21. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Cur Opin Periodontol 1996;3:85-96.
22. Chowdbury MH, Moak SA, Rifkin BR, Greenwald RA. Effect of tetracyclines which have metalloproteinase inhibitory capacity on basal and heparin stimulated bone resorption by chick osteoclasts. Agents Actions 1993;40:124-8.
23. Reynolds JJ, Dingle JT. A sensitive in vitro method for studying the induction and inhibition of bone resorption. Calcif Tissue Res 1970;4:339-49.
24. Horowitz SM, Algan SA, Purdon MA. Pharmacologic inhibition of particulate-induced bone resorption. J Biomed Mat Res 1996;31:91-6.
25. Sabokhar A, Fujikawa Y, Neale S, Murray DW, Athanasou NA. Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 1997;56:414-20.
26. Doyle A, Griffiths JB. Haemocytometer cell counts and viability studies. In: Cell and tissue culture for medical research. John Wiley & Sons Ltd, 2000:12-6.
27. Greenwald RA, Golub LM, Ramamurthy S, et al. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone 1998;22:33-8.
28. Ramamurthy N, Bain S, Liang CT, et al. A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study. Carr Med Chem 2001;8:295-303.
29. Green J. The physiochemical structure of bone: cellular and non cellular elements. Miner Electrolyte Metab 1994;20:7-15.
30. Vernillo AT, Ramamurthy NS, Golub LM, Rifkin BR. The nonanti-microbial properties of tetracycline for the treatment of periodontal disease. Curr Opin Periodontol 1994;111-8.
31. Doxycycline. In: Dollery C, ed. Therapeutic drugs. 2nd edition. Churchill Livingstone 1999.
32. Pandey R, Quinn JM, Sabokbar A, Athanasou NA. Bisphosphonate inhibition of bone resorption induced by particulate biomaterial-associated macrophages. Acta Orthop Scand 1996;67:221-8.
33. Shanbhag AS, Hasselman CT, Rubash HE. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 1997;344:33-43.
34. Pollice PF, Rosier RN, Looney RJ, et al. Oral pentoxyfylline inhibits release of tumour necrosis factor-alpha from human peripheral blood monocytes: a potential treatment for aseptic loosening of total joint components. J Bone Joint Surg [Am] 2001;83-A:1057-61.
35. Schwarz EM, Benz EB, Lu AP, et al. Quantitative small animal surrogate to evaluate drug efficacy in preventing wear debris induced osteolysis. J Orthop Res 2000;18:849-55.